PetMed Express Inc (PETS)
Official siteHEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ
Market Cap: $20.90M
Last updated: Nov 17, 2026 at 11:03 AM ET
PetMed Express Inc (PETS) Valuation Multiples
PetMed Express (PETS) trades at 0.1x sales and 1.1x book value. Its P/S of 0.1x is below its 5-year median of 0.5x. Its forward P/E is 16.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 16.7x |
| Price to sales | 0.1x |
| Price to book | 1.1x |
| PEG | N/A |
| FCF yield | -130.4% |
Historical Medians
Against its 10-year medians, its P/S is 94.1% below 1.7x and its P/B is 67.6% below 3.4x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.1x | 0.5x | 1.7x |
| P/B | 1.1x | 1.7x | 3.4x |
Valuation History
Over the 8 of the 10 year ends shown that have a P/E, its P/E ranged from 11.5x in 2018 to 482.0x in 2024. 2024 was the highest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $3.20 | N/A | N/A | 2.1x |
| 2024 | $4.82 | 482.0x | 0.4x | 1.0x |
| 2023 | $7.56 | N/A | 0.6x | 1.5x |
| 2022 | $17.70 | 27.7x | 1.4x | 3.1x |
| 2021 | $25.26 | 23.2x | 1.9x | 3.6x |
| 2020 | $32.06 | 20.8x | 2.1x | 4.6x |
| 2019 | $23.52 | 18.8x | 1.7x | 3.7x |
| 2018 | $23.26 | 11.5x | 1.7x | 3.6x |
| 2017 | $45.50 | 26.9x | 3.4x | 8.4x |
| 2016 | $23.07 | 21.6x | 1.9x | 5.2x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PETS
What is PETS's forward P/E ratio?
PetMed Express has a forward P/E ratio of 16.7x.
Is PETS stock overvalued?
GNG's valuation label for PETS is Undervalued.
What is PETS's price to sales ratio?
PetMed Express has a price to sales ratio of 0.1x.
PETS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors